Followers | 19 |
Posts | 6384 |
Boards Moderated | 2 |
Alias Born | 05/23/2019 |

Thursday, May 15, 2025 5:26:43 PM
“We’re called Elevated Softgels for a reason – we make the best softgels in industry. Guaranteed.
We also manufacture tinctures, and recently added the capability manufacture over a million gummies per month, but softgels are our specialty.
It takes very expensive equipment and specialized skills to make softgels, all of which we’ve invested a tremendous amount of time and energy into procuring. Our experienced team has collectively been manufacturing softgels in the industry for 10+ years. Rely on our manufacturing expertise so that you can focus on what you do best, get more customers
https://elevatedsoftgels.com/

Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2025 09:25:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/27/2025 09:03:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2025 01:25:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:28:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:27:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2025 10:27:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2025 10:04:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2024 09:17:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 09:38:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 09:06:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 02:17:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:54:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 01:28:43 PM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM
VAYK Project 100% Revenue Growth Before Half Year Report • VAYK • Jul 14, 2025 8:58 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM